Descriptions

HoxA7 is a sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. This protein possesses intrinsically disordered regions (IDRs) with large negative charge, some of which involve a consecutive sequence of aspartate (D) or glutamate (E) residues, known as D/E repeats. These D/E repeats can cause autoinhibition through intramolecular electrostatic interaction with HMG boxes and modulate binding to DNA. This autoinhibited state can transition into the uninhibited complex with DNA through an electrostatically driven induced-fit process, which accelerates the target DNA search kinetics in the presence of non-functional high-affinity ligands ('decoys').

Autoinhibitory domains (AIDs)

Target domain

128-192 (DNA-binding domain)

Relief mechanism

Assay

Accessory elements

No accessory elements

References

Autoinhibited structure

Activated structure

1 structures for P31268

Entry ID Method Resolution Chain Position Source
AF-P31268-F1 Predicted AlphaFoldDB

276 variants for P31268

Variant ID(s) Position Change Description Diseaes Association Provenance
rs149657061 2 S>G No ESP
ExAC
TOPMed
gnomAD
rs781611799 2 S>I No ExAC
gnomAD
rs781611799 2 S>N No ExAC
gnomAD
rs757369844 3 S>Y No ExAC
gnomAD
rs866752726 4 S>L No TOPMed
gnomAD
rs751666779 4 S>P No ExAC
TOPMed
gnomAD
rs758495730 8 N>D No ExAC
TOPMed
gnomAD
rs765702602 9 A>G No ExAC
gnomAD
rs907646153 9 A>T No TOPMed
rs1309115771 10 L>R No TOPMed
gnomAD
rs759944196 12 S>I No ExAC
TOPMed
gnomAD
rs371532380 13 K>R No ESP
ExAC
gnomAD
rs377689779 14 Y>* No ESP
ExAC
TOPMed
gnomAD
rs1161572722 15 T>A No gnomAD
rs1379798108 16 A>G No gnomAD
rs145778968 17 G>A No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs145778968 17 G>E No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs78410337 17 G>R No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs78410337 17 G>W No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs2301721 18 A>P No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
VAR_028001
rs2301721
18 A>T No UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs550774120 19 S>A No 1000Genomes
gnomAD
rs745678681 21 F>I No ExAC
gnomAD
rs530671173 24 A>T No 1000Genomes
ExAC
TOPMed
gnomAD
rs1284749326 25 E>* No gnomAD
rs771200839 25 E>G No ExAC
gnomAD
rs1284749326 25 E>Q No gnomAD
rs747255380 26 P>S No ExAC
gnomAD
rs758448332 27 T>I No ExAC
TOPMed
gnomAD
rs758448332 27 T>S No ExAC
TOPMed
gnomAD
rs979099678 29 C>F No TOPMed
rs752752010 29 C>G No ExAC
gnomAD
COSM4824345
rs755438662
30 S>F Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
ExAC
NCI-TCGA
TOPMed
gnomAD
rs866074728 32 A>V No Ensembl
rs761087427 33 P>R No ExAC
TOPMed
gnomAD
rs766593338 33 P>S Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
gnomAD
rs193124013 34 N>K No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1018055387 36 Q>R No TOPMed
rs1422982625 38 S>R No TOPMed
gnomAD
rs765294385 39 G>C Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
gnomAD
rs765294385 39 G>R No ExAC
gnomAD
rs765294385 39 G>S Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
gnomAD
rs139653572 39 G>V No ESP
ExAC
TOPMed
gnomAD
rs770701724 40 Y>* No ExAC
gnomAD
rs776620721 40 Y>H No ExAC
TOPMed
gnomAD
rs776620721 40 Y>N No ExAC
TOPMed
gnomAD
TCGA novel 41 G>E Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs746792177 41 G>R No ExAC
TOPMed
gnomAD
rs746792177 41 G>W No ExAC
TOPMed
gnomAD
rs748260443 42 A>V No ExAC
gnomAD
rs1346956477 43 G>D No gnomAD
COSM3928998 44 A>T Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs778899843 44 A>V No ExAC
gnomAD
rs1207033824 45 G>S Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
TOPMed
COSM6110128 46 A>P Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1233857798 46 A>T Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
TOPMed
rs879105208 47 F>V No Ensembl
rs756474411 48 A>G No ExAC
TOPMed
gnomAD
rs749850344 48 A>P No ExAC
TOPMed
gnomAD
rs749850344 48 A>T No ExAC
TOPMed
gnomAD
rs756474411 48 A>V No ExAC
TOPMed
gnomAD
rs878972024 49 S>A No Ensembl
rs750774350 49 S>L Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
rs1029466417 51 V>A No Ensembl
rs764900202 52 P>Q No ExAC
gnomAD
rs1457386778 53 G>S No gnomAD
rs759115973 53 G>V No ExAC
rs1172350298 55 Y>C No gnomAD
rs776477605 55 Y>H No ExAC
gnomAD
rs766322170 56 N>K No ExAC
gnomAD
rs1476627731 56 N>S No TOPMed
gnomAD
TCGA novel 57 V>A Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs760410079 57 V>G No ExAC
gnomAD
COSM1088874 57 V>I Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs772288938 58 N>D No ExAC
TOPMed
gnomAD
rs1269033672 58 N>S No gnomAD
COSM1312998 58 N>Y Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1209746860 59 S>N No gnomAD
rs748309582 59 S>R No ExAC
TOPMed
gnomAD
rs1562738126 60 P>T No Ensembl
rs1253448405 61 L>F No gnomAD
rs1344928638 63 Q>H No Ensembl
rs559354439 64 S>N No 1000Genomes
ExAC
gnomAD
rs768791120 64 S>R No ExAC
TOPMed
gnomAD
COSM1088873 65 P>S Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
COSM600783
COSM6110130
rs1384986017
65 P>T lung Variant assessed as Somatic; MODERATE impact. [Cosmic, NCI-TCGA] No cosmic curated
NCI-TCGA Cosmic
NCI-TCGA
TOPMed
rs1038275564 67 A>V No Ensembl
rs756592104 69 G>C No ExAC
gnomAD
rs1006250755 69 G>V No TOPMed
rs1359389813 70 Y>N No TOPMed
rs781551044 71 G>D No ExAC
gnomAD
TCGA novel 72 L>M Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1274092644 74 A>G No TOPMed
rs752468389 74 A>T No ExAC
gnomAD
rs1583421468 75 D>A No Ensembl
COSM746308 75 D>N Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1399312973 76 A>T No gnomAD
rs529254085 76 A>V No ExAC
TOPMed
gnomAD
rs563708052 77 Y>* No ExAC
gnomAD
rs766259696
COSM1088872
78 G>D Variant assessed as Somatic; MODERATE impact. endometrium [NCI-TCGA, Cosmic] No NCI-TCGA Cosmic
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs753340327 78 G>S No ExAC
gnomAD
rs760595034 79 N>D No ExAC
TCGA novel 79 N>H Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1420195665 79 N>I No TOPMed
gnomAD
rs1420195665 79 N>S No TOPMed
gnomAD
rs750200293
COSM1088871
82 C>* Variant assessed as Somatic; HIGH impact. endometrium [NCI-TCGA, Cosmic] No NCI-TCGA Cosmic
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs750200293 82 C>W No ExAC
TOPMed
gnomAD
rs1434462964 83 A>T No gnomAD
rs921688382 83 A>V No TOPMed
rs144742215 84 S>A No ESP
gnomAD
rs144742215 84 S>T No ESP
gnomAD
rs974835724 85 Y>* No TOPMed
rs1450272157 86 D>G Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
TOPMed
gnomAD
rs767355645 86 D>N No ExAC
TOPMed
gnomAD
rs1469095750 87 Q>R No TOPMed
rs761589955 89 I>M No ExAC
gnomAD
TCGA novel 89 I>P Variant assessed as Somatic; HIGH impact. [NCI-TCGA] No NCI-TCGA
rs1045191807 90 P>A No gnomAD
rs1239787579 90 P>L No TOPMed
gnomAD
rs1045191807 90 P>S No gnomAD
COSM400291 91 G>R Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1311317501 91 G>W No gnomAD
rs762960362 93 C>S No ExAC
TOPMed
gnomAD
rs762960362 93 C>Y No ExAC
TOPMed
gnomAD
rs1056530813 94 S>G No gnomAD
rs1337197232 95 D>A No gnomAD
rs1171656723 99 G>D No gnomAD
rs1342947011 99 G>S No TOPMed
rs746326146 100 A>T No ExAC
gnomAD
rs781764041 100 A>V No ExAC
TOPMed
gnomAD
rs377596605 101 C>* No ESP
ExAC
gnomAD
rs935605212 101 C>Y No gnomAD
rs1439661851 102 D>N No gnomAD
rs747359929 103 K>E No ExAC
gnomAD
rs35510017
COSM452920
103 K>R breast [Cosmic] No cosmic curated
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs754637278 104 T>M No ExAC
gnomAD
rs769859237 105 D>E No ExAC
TOPMed
gnomAD
rs1222044457 105 D>N No TOPMed
rs750440722 106 E>D No ExAC
TOPMed
gnomAD
rs779561079 106 E>Q No ExAC
gnomAD
rs1000360737 108 A>S No TOPMed
gnomAD
rs1000360737 108 A>T No TOPMed
gnomAD
TCGA novel 108 A>V Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs761645013 109 L>P No ExAC
gnomAD
TCGA novel 110 H>N Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1338494214 111 G>V No gnomAD
rs769984771 112 A>T Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
gnomAD
rs1295878557 114 E>A No gnomAD
rs1562737958 114 E>Q No Ensembl
rs777330616 115 A>T No ExAC
gnomAD
rs771520037 115 A>V No ExAC
gnomAD
rs1471991218 117 F>S No gnomAD
rs1196973946 118 R>G No TOPMed
rs778216909 118 R>L No ExAC
TOPMed
gnomAD
rs778216909 118 R>P No ExAC
TOPMed
gnomAD
rs1277880163 120 Y>N No gnomAD
rs779567620 121 P>H No ExAC
rs749030294 121 P>S No ExAC
gnomAD
rs755689640 122 W>R No ExAC
gnomAD
rs1216063088 123 M>L No gnomAD
rs544001319 124 R>P No 1000Genomes
ExAC
gnomAD
rs544001319 124 R>Q No 1000Genomes
ExAC
gnomAD
rs865788066 124 R>W No gnomAD
rs1401927444 125 S>F No TOPMed
rs772553123 127 G>A No ExAC
TCGA novel 127 G>E Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs900847750 128 P>L No Ensembl
rs1036671085 129 D>E No TOPMed
gnomAD
TCGA novel 130 R>M Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs939771927 132 R>Q No Ensembl
rs1562737529 132 R>W No Ensembl
rs745409883 133 G>D No ExAC
gnomAD
rs780609860 134 R>L No ExAC
TOPMed
gnomAD
rs1276150189 136 T>P No gnomAD
rs982907728 137 Y>C No TOPMed
rs1331097182 138 T>M No TOPMed
gnomAD
rs762508295 139 R>P Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No Ensembl
NCI-TCGA
rs1407134241 139 R>S No gnomAD
rs747004706 141 Q>* No ExAC
gnomAD
rs747004706 141 Q>E No ExAC
gnomAD
rs777542472 142 T>A No ExAC
gnomAD
rs1170206862 142 T>M No gnomAD
TCGA novel 146 E>K Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs878859385 149 F>Y No Ensembl
rs1477746824
COSM3880409
150 H>Y Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
NCI-TCGA
gnomAD
rs765531291 153 R>G No ExAC
TOPMed
gnomAD
rs1179211280 153 R>P No gnomAD
rs765531291 153 R>S No ExAC
TOPMed
gnomAD
rs1583420652 154 Y>S No Ensembl
rs753980676 155 L>P No ExAC
gnomAD
rs766627218 156 T>A No ExAC
gnomAD
COSM3880408
rs559344881
156 T>M Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs559344881 156 T>R No 1000Genomes
ExAC
TOPMed
gnomAD
rs774535792 157 R>G No ExAC
TOPMed
gnomAD
rs1343684367
COSM317468
157 R>L lung [Cosmic] No cosmic curated
TOPMed
gnomAD
rs1343684367 157 R>Q No TOPMed
gnomAD
rs774535792 157 R>W No ExAC
TOPMed
gnomAD
rs769491087 158 R>C No ExAC
TOPMed
gnomAD
rs1449685607 158 R>H No gnomAD
rs576810987 159 R>H No 1000Genomes
ExAC
gnomAD
COSM746309 159 R>L Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
COSM184301
rs1361050955
160 R>H Variant assessed as Somatic; MODERATE impact. large_intestine [NCI-TCGA, Cosmic] No cosmic curated
NCI-TCGA
gnomAD
rs1368746193 160 R>S No TOPMed
rs919990927 161 I>T No TOPMed
COSM333707
rs201959803
161 I>V lung [Cosmic] No cosmic curated
1000Genomes
ExAC
TOPMed
gnomAD
rs375101630 163 I>V No ESP
ExAC
TOPMed
gnomAD
rs758229054 166 A>P No ExAC
gnomAD
TCGA novel 166 A>T Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
COSM1568450 166 A>V Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs754810820 170 T>A No ExAC
TOPMed
gnomAD
rs1335089145 170 T>S No TOPMed
rs780389627
COSM4414555
172 R>C Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
ExAC
NCI-TCGA
gnomAD
rs1562737385 172 R>H No Ensembl
TCGA novel 174 I>F Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs750418651 175 K>R No ExAC
gnomAD
COSM1450195 176 I>L Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs768096835 177 W>* No ExAC
TOPMed
gnomAD
rs768096835 177 W>C No ExAC
TOPMed
gnomAD
rs1309185969 179 Q>H No gnomAD
rs751967060 181 R>G No ExAC
gnomAD
COSM1254349 181 R>H Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1562737367 181 R>L No Ensembl
rs764422900
COSM1088869
182 R>H Variant assessed as Somatic; MODERATE impact. endometrium [NCI-TCGA, Cosmic] No NCI-TCGA Cosmic
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs764422900 182 R>L No ExAC
TOPMed
gnomAD
COSM1088868 184 K>E Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs927986090 184 K>N No TOPMed
COSM1088867 186 K>N Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1301265808 187 K>T No gnomAD
rs374828544 189 H>R No ESP
rs776316860 190 K>N No ExAC
gnomAD
rs1378345862 191 D>H No gnomAD
COSM3637739
rs770523270
192 E>K Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
ExAC
NCI-TCGA
rs1031543455 193 G>D No TOPMed
gnomAD
rs760210246 193 G>S Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
TOPMed
gnomAD
rs1031543455 193 G>V No TOPMed
gnomAD
rs571549143 194 P>L No ExAC
gnomAD
rs978085273 195 T>I No TOPMed
rs772065138 196 A>G No ExAC
TOPMed
gnomAD
COSM1088866 196 A>V Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs147555041 197 A>S No 1000Genomes
ExAC
gnomAD
rs749066787 200 P>A No ExAC
gnomAD
rs749066787 200 P>S No ExAC
gnomAD
rs200468253 201 E>K No ExAC
TOPMed
gnomAD
rs200468253 201 E>Q No ExAC
TOPMed
gnomAD
rs371795704 203 A>S No ESP
gnomAD
rs750517268 203 A>V No ExAC
TOPMed
gnomAD
rs757346004 204 V>L No ExAC
gnomAD
rs1341434143 205 P>L No gnomAD
rs764552031 206 S>F Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
rs954358815 207 A>V No Ensembl
rs368771286 208 A>P No ESP
ExAC
TOPMed
gnomAD
rs368771286 208 A>S No ESP
ExAC
TOPMed
gnomAD
rs138411797 209 A>T No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1342151391 209 A>V No TOPMed
rs1423826860 212 A>G No gnomAD
rs1423826860 212 A>V No gnomAD
rs370998918 213 A>E No ESP
ExAC
TOPMed
gnomAD
rs760187331 213 A>S No ExAC
gnomAD
rs760187331 213 A>T No ExAC
gnomAD
rs370998918 213 A>V No ESP
ExAC
TOPMed
gnomAD
rs771551984 214 D>N No ExAC
gnomAD
rs115619001 215 K>N No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs370786847 217 D>E No ESP
ExAC
TOPMed
gnomAD
rs140671509 217 D>N No ESP
ExAC
TOPMed
gnomAD
rs140671509 217 D>Y No ESP
ExAC
TOPMed
gnomAD
rs565645084 218 E>K Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No 1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs565645084 218 E>Q No 1000Genomes
ExAC
TOPMed
gnomAD
rs757318981 219 E>D No ExAC
TOPMed
gnomAD
rs781471186 219 E>G No ExAC
gnomAD
COSM1241276 219 E>missing Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs200815896 221 D>E No ExAC
TOPMed
gnomAD
rs1265710721 221 D>V No TOPMed
rs146964934 225 E>D No 1000Genomes
ESP
TOPMed
gnomAD
rs778284810 227 D>N No ExAC
TOPMed
gnomAD
rs143079352 228 E>K No ESP
ExAC
gnomAD
rs1562737167 229 E>D No Ensembl

No associated diseases with P31268

No regional properties for P31268

Type Name Position InterPro Accession
No domain, repeats, and functional sites for P31268

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
nuclear membrane Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

6 GO annotations of molecular function

Name Definition
DNA-binding transcription activator activity, RNA polymerase II-specific A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II.
DNA-binding transcription factor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.
DNA-binding transcription factor binding Binding to a DNA-binding transcription factor, a protein that interacts with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.
sequence-specific DNA binding Binding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
sequence-specific double-stranded DNA binding Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding.

12 GO annotations of biological process

Name Definition
angiogenesis Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
anterior/posterior pattern specification The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
embryonic skeletal system morphogenesis The process in which the anatomical structures of the skeleton are generated and organized during the embryonic phase.
negative regulation of cell-matrix adhesion Any process that stops, prevents, or reduces the rate or extent of cell adhesion to the extracellular matrix.
negative regulation of DNA-templated transcription Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
negative regulation of keratinocyte differentiation Any process that stops, prevents, or reduces the frequency, rate or extent of keratinocyte differentiation.
negative regulation of leukocyte migration Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte migration.
negative regulation of monocyte differentiation Any process that stops, prevents, or reduces the frequency, rate or extent of monocyte differentiation.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
stem cell differentiation The process in which a relatively unspecialized cell acquires specialized features of a stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.

11 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P23459 HOXD8 Homeobox protein Hox-D8 Gallus gallus (Chicken) PR
A2T6Z0 HOXB1 Homeobox protein Hox-B1 Pan troglodytes (Chimpanzee) SS
P10105 lab Homeotic protein labial Drosophila melanogaster (Fruit fly) EV
P49639 HOXA1 Homeobox protein Hox-A1 Homo sapiens (Human) SS
P14653 HOXB1 Homeobox protein Hox-B1 Homo sapiens (Human) SS
P09022 Hoxa1 Homeobox protein Hox-A1 Mus musculus (Mouse) SS
O08656 Hoxa1 Homeobox protein Hox-A1 Rattus norvegicus (Rat) SS
A2D649 HOXB1 Homeobox protein Hox-B1 Macaca mulatta (Rhesus macaque) SS
Q28IU6 hoxd1 Homeobox protein Hox-D1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) SS
Q8JH55 hoxb8b Homeobox protein Hox-B8b Danio rerio (Zebrafish) (Brachydanio rerio) PR
F1Q4R9 meox1 Homeobox protein MOX-1 Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MSSSYYVNAL FSKYTAGASL FQNAEPTSCS FAPNSQRSGY GAGAGAFAST VPGLYNVNSP
70 80 90 100 110 120
LYQSPFASGY GLGADAYGNL PCASYDQNIP GLCSDLAKGA CDKTDEGALH GAAEANFRIY
130 140 150 160 170 180
PWMRSSGPDR KRGRQTYTRY QTLELEKEFH FNRYLTRRRR IEIAHALCLT ERQIKIWFQN
190 200 210 220
RRMKWKKEHK DEGPTAAAAP EGAVPSAAAT AAADKADEED DDEEEEDEEE